Berenberg cuts L’Oreal stock price target to €454 from €502

Published 10/02/2025, 14:30
Berenberg cuts L’Oreal stock price target to €454 from €502

On Monday, Berenberg analysts adjusted their outlook on L’Oreal SA (OR:FP) (OTC: LRLCY), lowering the price target to €454 from the previous €502, while maintaining a Buy rating on the stock. Currently trading at $70.25, the stock appears undervalued according to InvestingPro analysis, with broader analyst targets ranging from $88 to $94.40. The decision comes after L’Oreal’s full-year 2024 results, released on February 7, showed mixed performance against market expectations.

L’Oreal’s like-for-like sales growth in the fourth quarter was 2.5%, falling short of the Visible Alpha consensus forecast of 3.9%. The company experienced varied growth rates across its divisions, with Professional Products up by 3.8% versus a 5.3% consensus, Consumer Products slightly better at 2.7% compared to a 1.9% consensus, Luxe at 1% against a 5% consensus, and Dermatological Beauty exceeding expectations at 5% growth compared to a 4.8% consensus. The company maintains impressive gross profit margins of 74.2%, reflecting its strong market position. Get deeper insights into L’Oreal’s financial metrics and 8 additional exclusive ProTips with InvestingPro.

Regionally, L’Oreal’s organic sales growth also presented a mixed picture. Europe saw a growth of 5.2%, just under the 5.4% consensus. North America reported a lower-than-anticipated growth of 1.4%, compared to the expected 4.7%, and North Asia experienced a decline of 3.6%, which was worse than the -2.4% consensus had predicted.

Despite these variations in sales growth, the actual sales for Q4 2024 totaled €11,081 million, surpassing consensus estimates by 2%. The company’s operating profit for the fiscal year 2024 reached €8,688 million, aligning with expectations, and resulted in an operating margin of 20.0%. Moreover, L’Oreal’s adjusted earnings per share (EPS) for FY24 was €12.66, which was 4% higher than the consensus forecast. InvestingPro data shows the company maintains a strong financial health score of GOOD, with robust cash flows and moderate debt levels, indicating some positive aspects amidst a complex performance landscape.

In other recent news, L’Oreal SA has seen adjustments in its outlook from financial analysts. Stifel has revised its price target for the company’s stock down to EUR 395 from EUR 410, maintaining a Buy rating. This change follows L’Oreal’s lower than expected sales growth in the last quarter of 2024, particularly in North America and North Asia. However, the firm noted L’Oreal’s Luxe segment in the United States saw robust sales increases during November and December.

On the other hand, Bernstein SocGen Group has downgraded L’Oreal’s stock rating from Outperform to Market Perform, and adjusted the price target to EUR 380 from EUR 430. The firm anticipates a normalization year for the beauty industry in 2025, following a challenging 2024. Bernstein’s new price target is based on an enterprise value to earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) multiple of 15.0x, slightly reduced from the previous 15.2x.

These are recent developments in the financial analysis of L’Oreal, indicating careful scrutiny from analysts as they navigate shifts in the beauty industry and the company’s performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.